The February microcap IPO flow slowed for Presidents Day week, a typical seasonal lull, with four companies on the calendar.
The companies include a provider of maritime tours, attractions, and activities in the US and US Virgin Islands, a financial and advertising software company using blockchain for companies to list, sell, and buy advertising campaigns, a Phase 1 biotech focused on developing sublingual delivery of proteins and peptides for metabolic diseases such as NASH and diabetes, and a manufacturer and distributor of power sports vehicles and motor boats.
Updated IPOs
Amphitrite Digital (AMDI) had estimated IPO dates of Feb. 8 and Feb. 14, intending to raise $7 million at an almost $13 million market cap. The company now has an estimated IPO date of Feb. 21, still aiming to raise $7 million at the same market cap.
NYIAX (NYX) had an estimated IPO date of March 8, 2023, seeking to raise $9 million at a market cap of about $78 million. Then, the company had estimated IPO dates of Nov. 3 and Nov. 30, 2023, aiming to raise $7.5 million at around a $74 million market cap. NYIAX then moved the estimated IPO date to Feb. 16, increasing the planned offering to about $8 million at around a $75 million market cap. Now, the company has an estimated IPO date of Feb. 22 and is still seeking to raise $8 million at a $75 million market cap.
Biolingus (Cayman) Limited (SUBL) had estimated IPO dates of Jan. 31 and Feb. 14, aiming to raise $7 million at about a $222 million market cap. The company now has an estimated IPO date of Feb. 23, still intending to raise $7 million at the same market cap.
Massimo Group (MAMO) had an estimated IPO date of Feb. 13, seeking to raise almost $6 million at around a $186 market cap. The company now has an estimated IPO date of Feb. 23 and still intends to raise around $6 million at the same market cap.